121 related articles for article (PubMed ID: 7689676)
1. Analysis of candidate human blood stem cells in "humanized" immune-deficiency SCID mice.
Péault B; Weissman I; Baum C
Leukemia; 1993 Aug; 7 Suppl 2():S98-101. PubMed ID: 7689676
[TBL] [Abstract][Full Text] [Related]
2. Thy-1-expressing CD34+ human cells express multiple hematopoietic potentialities in vitro and in SCID-hu mice.
Péault B; Weissman IL; Buckle AM; Tsukamoto A; Baum C
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):91-3. PubMed ID: 7685521
[TBL] [Abstract][Full Text] [Related]
3. Analysis of human hematopoietic stem cell populations.
Murray L; DiGiusto D; Chen B; Chen S; Combs J; Conti A; Galy A; Negrin R; Tricot G; Tsukamoto A
Blood Cells; 1994; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
[TBL] [Abstract][Full Text] [Related]
4. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
[TBL] [Abstract][Full Text] [Related]
5. Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells.
Joo SY; Chung YS; Choi B; Kim M; Kim JH; Jun TG; Chang J; Sprent J; Surh CD; Joh JW; Kim SJ
Transplantation; 2012 Dec; 94(11):1095-102. PubMed ID: 23222735
[TBL] [Abstract][Full Text] [Related]
6. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
Ramírez M; Rottman GA; Shultz LD; Civin CI
Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
[TBL] [Abstract][Full Text] [Related]
7. High-level expression of a novel epitope of CD59 identifies a subset of CD34+ bone marrow cells highly enriched for pluripotent stem cells.
Hill B; Rozler E; Travis M; Chen S; Zannetino A; Simmons P; Galy A; Chen B; Hoffman R
Exp Hematol; 1996 Jul; 24(8):936-43. PubMed ID: 8690053
[TBL] [Abstract][Full Text] [Related]
8. Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft.
Fraser CC; Kaneshima H; Hansteen G; Kilpatrick M; Hoffman R; Chen BP
Blood; 1995 Sep; 86(5):1680-93. PubMed ID: 7655000
[TBL] [Abstract][Full Text] [Related]
9. Improved T and B cell recovery by the transfer of slowly dividing human hematopoietic stem cells.
Vitacolonna M; Schubert M; Herbert N; Taubert I; Singh R; Ho A; Zöller M
Leuk Res; 2010 May; 34(5):622-30. PubMed ID: 19906424
[TBL] [Abstract][Full Text] [Related]
10. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
11. Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice.
Chen BP; Galy A; Kyoizumi S; Namikawa R; Scarborough J; Webb S; Ford B; Cen DZ; Chen SC
Blood; 1994 Oct; 84(8):2497-505. PubMed ID: 7522631
[TBL] [Abstract][Full Text] [Related]
12. Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells.
Plavec I; Voytovich A; Moss K; Webster D; Hanley MB; Escaich S; Ho KE; Böhnlein E; DiGiusto DL
Gene Ther; 1996 Aug; 3(8):717-24. PubMed ID: 8854097
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
[TBL] [Abstract][Full Text] [Related]
14. Analysis of human blood cell development in the SCID-hu mouse, an in vivo replica of the human fetal hematopoietic system.
Péault B
C R Acad Sci III; 1993 Sep; 316(9):902-8. PubMed ID: 7521269
[TBL] [Abstract][Full Text] [Related]
15. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice.
Ueda T; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K
Stem Cells; 2000; 18(3):204-13. PubMed ID: 10840074
[TBL] [Abstract][Full Text] [Related]
17. Age-related changes in human hematopoietic stem/progenitor cells.
Kuranda K; Vargaftig J; de la Rochere P; Dosquet C; Charron D; Bardin F; Tonnelle C; Bonnet D; Goodhardt M
Aging Cell; 2011 Jun; 10(3):542-6. PubMed ID: 21418508
[TBL] [Abstract][Full Text] [Related]
18. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources.
Noort WA; Wilpshaar J; Hertogh CD; Rad M; Lurvink EG; van Luxemburg-Heijs SA; Zwinderman K; Verwey RA; Willemze R; Falkenburg JH
Bone Marrow Transplant; 2001 Jul; 28(2):163-71. PubMed ID: 11509934
[TBL] [Abstract][Full Text] [Related]
19. Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow.
Wilpshaar J; Noort WA; Kanhai HH; Willemze R; Falkenburg JH
Haematologica; 2001 Oct; 86(10):1021-8. PubMed ID: 11602407
[TBL] [Abstract][Full Text] [Related]
20. SCID-hu mice as a model to study tolerance after fetal stem cell transplantation.
Roncarolo MG; Vandekerckhove B
Bone Marrow Transplant; 1992; 9 Suppl 1():83-4. PubMed ID: 1354529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
